Association of the use of nonfood prebiotics, probiotics, and synbiotics with total and cause-specific mortality: a prospective cohort study

• Published in: Nutrition journal Vol. 24; no. 1; p. 45
• Main Authors: Zheng, Luyan, Zhang, Jiaqi, Yang, Jing, Wang, Yanbo, Zhang, Yina, Fang, Kailu, Wu, Jie, Zheng, Min
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 20.03.2025; BioMed Central; BMC
• Subjects: Adult; Aged; Analysis; Cause of Death; cohort studies; death; Dietary supplements; Female; females; Health aspects; heart; Heart diseases; Heart Diseases - mortality; Humans; Hypertension; Male; Middle Aged; Mortality; National Health and Nutrition Examination Survey; Neoplasms - mortality; Nonfood; Nutrition Surveys; Prebiotics; Prebiotics - administration & dosage; Probiotics; Probiotics - administration & dosage; Proportional Hazards Models; Prospective Studies; risk; Surveys; Synbiotics; Synbiotics - administration & dosage; United States; United States; United Kingdom; Probiotics; Nonfood; Mortality; Synbiotics; Prebiotics
• ISSN: 1475-2891; 1475-2891
• DOI: 10.1186/s12937-025-01104-w

The use of nonfood prebiotics, probiotics, and synbiotics has approximately tripled in the last 20 years. It is necessary to examine the associations of these substances with all-cause and cause-specific mortality in a large prospective cohort. This study included 53,333 adults from the National Health and Nutrition Examination Survey 1999-2018. All participants answered questions on the use of dietary supplements and medications, including prebiotics, probiotics, and synbiotics. Death outcomes were determined by linkage to National Death Index records through 31 December 2019. Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for mortality from all causes, heart diseases, cancer, and other causes. During a mean follow-up of 10.6 years, 9117 deaths were documented, including 2364 heart disease deaths, 1964 cancer deaths, and 4700 other causes deaths. Compared to nonusers, nonfood prebiotic, probiotic, and synbiotic users had a 59% (HR 0.41, 95% CI 0.30 to 0.56), 56% (HR 0.44, 95% CI 0.26 to 0.74), 49% (HR 0.51, 95% CI 0.31 to 0.83), and 64% (HR 0.36, 95% CI 0.23 to 0.59) for lower risk of all-cause, cancer, heart disease, and other causes mortality, respectively. Moreover, the inverse association of the use of prebiotics, probiotics, and synbiotics with mortality was stronger in female participants and participants without hypertension. The use of nonfood prebiotics, probiotics, and synbiotics is significantly associated with lower all-cause mortality, as well as deaths from heart disease, cancer, and other causes.